See Clearly.
Again.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo tellus et suscipit. Nullam et odio quis risus maximus consequat.ulputate
our vision
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo tellus et suscipit. Nullam et odio quis risus maximus consequ
EndoArt®:The future
of corneal transplants
EndoArt® is the first synthetic implant to treat corneal edema and save vision. We are breaking the barriers for corneas, the most common organ transplant worldwide.
Hyper-CL™:
Design to deliver
Hyper-CL™ therapeutic contact lens provides a novel solution for the treatment of corneal conditions, increasing bioavailability of any topical drop.
Bringing the
Beautyful Moments
Back into Focus.
The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL™ group. In addition, the therapeutic Hyper-CL™ group had a greater improvement in mean BCVA and mean CCT.
The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.
The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.
The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.
The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL™ group. In addition, the therapeutic Hyper-CL™ group had a greater improvement in mean BCVA and mean CCT.
The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.
Leading experts around the world trust our solution. Here's what they have to say:
Check out our latest posts and updates
News
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo
12.01.25
Publications
Devon hospital offers artificial cornea transplant
05.02.25 | BBC
Events
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo
29.11.24
You can already see the results:
The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL™ group. In addition, the therapeutic Hyper-CL™ group had a greater improvement in mean BCVA and mean CCT.
The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.
The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.
Check out our latest posts and updates
News
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo
12.01.25
Publications
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo
18.12.24
Events
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean tincidunt commodo
29.11.24
© All rights reserved to EyeYon Medical